ABSTRACT Arachidonic acid (AA) is an unsaturated fatty acid constituent of the phospholipid domain of cell membranes. It is subject to release via mobilization of phospholipases, particularly a cytoplasmic phospholipase A 2 . Thereafter, it may be metabolized by at least two cyclooxygenase (COX) isoforms to prostaglandins and related compounds, via lipoxygenases to leukotrienes and via p450-catalyzed metabolism to epoxyeicosatrienoic acids. Collectively, these bioactive lipids are termed eicosanoids. All of these lipids express potent bioactivity in vitro. Clinical studies have already demonstrated the importance of COX and lipoxygenase (LOX) products in human disease. The generation of models of COX, LOX and prostaglandin receptor gene inactivation is likely to broaden our insight into the importance of these compounds in vivo. Crystallization of the biosynthetic enzymes is likely to facilitate the development of highly specific inhibitors, as is the case already for COX-2. AA possesses intrinsic biological properties. It is also subject to free radical attack, generating isomeric eicosanoid species, the isoeicosanoids. These compounds may also express biological activity in vitro, although their importance in vivo is unclear. Development of specific assays for these compounds in urine suggests their utility as noninvasive indices of oxidant stress in vivo.
In 1934, von Euler identified a lipid-soluble substance from isoforms of the prostaglandin (PG) G/H synthase, colloquially known as cyclooxygenases (COX), catalyze the formation of semen that would stimulate uterine smooth muscle contrac-PG and related compounds. Vane (1971) first demonstrated tions and named it prostaglandin (von Euler 1934) . Bergström that COX was the target for aspirin inhibition of PG formaand Sjovall (1960) isolated prostaglandin E from sheep prostion. Inhibition of COX-1 in platelets, with consequent suptate glands and showed that it was a 20-carbon fatty acid pression of formation of thromboxane (Tx) A 2 , underlies the with blood pressure-lowering activity. Bergström et al (1964) efficacy of aspirin in the treatment of platelet-dependent vasdemonstrated the enzymatic conversion of arachidonic acid to cular occlusion (Patrono 1994) . prostaglandin E 2 . Because arachidonic acid is synthesized from Although the expression of COX-1 may be regulated, it is linoleic acid in humans, these discoveries established prostausually expressed constitutively. Similarly, although COX-2 glandins as a product of the metabolism of essential fatty acids. expression may be constitutive, particularly in the cells of the reproductive tract and in the nervous system (Yamagata et al.
EICOSANOIDS: FORMATION AND BIOLOGICAL
1993), its expression is usually tightly regulated, particularly ACTIVITY by cytokines, growth factors and tumor-promoting agents (Fu It is now known that arachidonic acid (AA) 4 is subject to et al. 1990 ). These observations have implicated COX-2 in metabolism by a wide array of bioactive lipid mediators. Two PG generation in inflammation and, perhaps, cancer (Tsujii et al. 1997) . COX-1, by contrast, is expressed constitutively in normal gastric epithelium. Inhibition of COX-1 is thought 
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BIOACTIVE LIPIDS AND HUMAN DISEASE
Although G protein-coupled receptors for all of the PG have been cloned (Narumiya 1994) , only the human pharmacology of specific antagonists of the TxA 2 receptor (TP) has been characterized to date. It is likely that the recent generation of mice deficient in each of these receptors will further elucidate their in vivo biology. Similarly, there have been suggestions that eicosanoids might activate nuclear receptors (Forman et al. 1997) . However, issues of specificity and concentration-response relationships with compounds actually formed in vivo must be resolved.
Lipoxygenases generate leukotrienes and related compounds. These lipids express biological properties of likely relevance to inflammatory responses in vivo. This is consistent with the phenotype expressed by mice deficient in the 5-lipoxygenase enzyme (Chen et al. 1994) . Specific antagonists of sulfidopeptide leukotrienes have found efficacy in human asthma, as have specific inhibitors of the 5-lipoxygenase (O'Byrne 1994). Leukotrienes and related compounds have also been implicated in neuronal function, atherogenesis, cellular proliferation and the regulation of vascular tone in vitro. Much less is known of the biological importance of the epoxygenase catalyzed formation of epoxyeicosatrienoic acids (EET) and related products, probably by p450 isozymes with ( Fig. 1 ; Waugh and Murphy 1996) . The relative abundance high affinity for arachidonic acid as a substrate (McGiff 1991) .
of formation of specific isomers in vivo is unknown, but to These compounds are potent regulators of epithelial ion transdate, the most extensively studied is a member of the IPF-IV port and vascular tone in vitro (Oyekan et al. 1994) . However, class, . This potent vasoconstrictor and mitogen specific receptors for EET have yet to be cloned, and animals is present in atherosclerotic plaque, but not in healthy vascular deficient in the AA-specific p450 isoforms (Wu et al. 1996) tissue . These effects of 8-epi PGF 2a are have yet to be generated. Data suggestive of their importance blocked by thromboxane receptor antagonists. Unlike thromin hypertension have been obtained with nonspecific inhibiboxane analogs, 8-epi PGF 2a induces platelet shape change tors (Makita et al. 1994) . However, given the absence of a without irreversible aggregation; it also acts with threshold specific means of pharmacological inhibition of their synthesis concentrations of conventional agonists to induce irreversible or action, their role in pathophysiology is speculative at presaggregation (Pratico et al. 1996) . However, high concentraent.
tions of 8-epi PGF 2a are necessary to activate the cloned splice In addition to these observations, cells may interact to genvariants of the human thromboxane receptor; its importance erate novel transcellular products of AA (Marcus 1990) . Simias an autacoid in vivo is unclear. larly, AA itself may directly modify cellular function. Thus, arachidonoylation of cellular proteins such as G proteins (Hal-DIFFERENTIAL ISOPROSTANE FORMATION lak et al. 1994) or miniglucagon (Sauvadet et al. 1997 ) may modify their effects. It may directly regulate ion channels (DaRather than estimating the formation of ''total'' F 2 isoprosmron et al. 1993) or influence gene expression (Barry et al. tanes by using a nonisoprostane internal standard, we have 1997). Differential allosteric regulation of the two COX isodeveloped specific assays for discrete members of the IPF classes forms by AA can cause dramatic differences in isoform selec- (Pratico et al. 1995) . Initially, we focused on the formation tivity for inhibitors, as a function of AA concentration (Swinof 8-epi PGF 2a by human platelets and monocytes in an atney et al. 1997).
tempt to characterize the mechanisms of isoprostane genera-A recent area of interest has been the potential importance tion. To our surprise, we found that 8-epi PGF 2a , but not other of oxidized lipids in the modification of cellular function (Lehr F 2 isoprostanes, could be formed as a minor product of the et al. 1997). The focus of this review will be on candidate COX-1 enzyme in platelets and the COX-2 isoform monocytes members of this species, a family of free radical-catalyzed (Pratico et al. 1995, Pratico and FitzGerald 1996) . These were products of arachidonic acid, the isoeicosanoids. potentially important observations, because activation of platelets or monocytes may be a feature of many syndromes putatively associated with oxidant stress. However, administra-THE ISOEICOSANOIDS tion of an aspirin regimen, designed to inhibit platelet COX-1, failed to suppress the elevated urinary 8-epi PGF 2a levels Isoeicosanoids, isomers of enzymatically derived eicosanoids, are free radical-catalyzed products of arachidonic acid that we observed in chronic smokers (Reilly et al. 1996a ), a syndrome of COX-1 activation. The same regimen signifi- (Nugteren and Christ-Hazelhof 1980, O'Connor et al. 1984) . The existence of the F 2 isoprostanes, isomers of PGF 2a , in cantly suppressed excretion of the 11-dehydro metabolite of thromboxane B 2 , which largely derives from platelets. Thus, human plasma and urine was first described by Morrow et al. (1990) . More recently, the free radical-dependent formation the capacity of platelets to form 8-epi PGF 2a in a COX-1-dependent manner did not appear to contribute in a measurof E 2 and D 2 isoprostanes, isothromboxanes and isoleukotrienes has been reported. able way to the urinary index of overall 8-epi PGF 2a biosynthesis. It is unknown to what extent, if any, the COX-2-depenFour classes of F 2 isoprostanes (IPF) have been described 436S SUPPLEMENT as lipoprotein oxidizability or the formation of adducts detected by spin trapping, relate to oxidant stress in vivo.
The measurement of F 2 isoprostanes may represent an important development in the assessment of free radical generation and oxidant stress in vivo. They are remarkably stable compounds. Coordinate elevation of plasma and urinary isoprostanes in syndromes of extrarenal oxidant stress (Morrow et al. 1995, Pratico and FitzGerald 1996) implies that little is likely to be gained by measurement of metabolites, rather than the parent products, in urine. However, estimates of 8-epi PGF 2a in plasma, where there is an abundance of lipid, may be confounded by its autooxidation ex vivo. Additionally, COX-1-dependent formation by platelets activated ex vivo might also undermine plasma-based measurements as indices of actual formation of 8-epi PGF 2a in vivo. Thus measurement of a metabolite of 8-epi PGF 2a (Roberts et al. 1996) might circumvent this problem if it is not formed in the cells of circulating blood. We have utilized gas chromatography/mass spectrometry to validate immunoassays of the parent compound. More recently, we have adopted an integrated approach that uses the coordinate measurement of urinary 8-epi PGF 2a and IPF 2a -I in the evaluation of oxidant stress in specific clinical settings. 
CLINICAL SYNDROMES
hyper-cholesterolemia (HFH). Correlation (r Å 0.57, P õ 0.0001; n Å 109).
There is a dose-dependent increase in urinary 8-epi PGF 2a excretion in apparently healthy chronic cigarette smokers, which was not suppressed by aspirin. Both cessation of smokdent pathway might contribute to the formation of 8-epi PGF 2a ing, with supplementation of nicotine patches and short-term in settings of inflammation and cellular proliferation, in which therapy with vitamin C (2000 mg/d), an endogenous antioxi-COX-2 induction might be expected.
dant, attenuated the elevation of urinary 8-epi PGF 2a excreDespite the apparent lack of relevance of the enzymatic tion. Deficiency of vitamin C (Heitzer 1996) may render smokformation of 8-epi PGF 2a to the use of its urinary excretion as ers particularly susceptible to the antioxidant effects of exogean index of oxidant stress, it seemed prudent to develop methnous vitamin supplementation. ods to measure another F 2 -isoprostane that was not susceptible Oxidation of LDL is thought to play a critical role in atheroto enzymatic formation. IPF 2a -I is a member of a distinct class genesis. This hypothesis is based largely on indirect evidence. of F 2 -isoprostanes (Waugh and Murphy 1996). It is not formed
We have recently immunolocalized 8-epi PGF 2a to monocyte/ by COX and its excretion in volunteers is not suppressed by macrophages and vascular smooth muscle cells in human athaspirin (Pratico et al 1998) . Urinary levels of IPF 2a -I and 8-erosclerotic plaque and demonstrated increased levels of this epi PGF 2a are closely correlated (r Å 0.57, P õ 0.0001) in compound in atherosclerotic vessels, compared with normal patients with hypercholesterolemia (Fig. 2) . This is a setting of arterial segments . Furthermore, we have moderate COX-1 activation. These observations are consistent demonstrated along with others that F 2 isoprostanes are formed with the hypothesis that excretion of both compounds in urine in LDL when it is oxidized in vitro. Therefore we designed reflects formation by a common mechanism-free radicalspecific studies to assess the biosynthesis of both 8-epi PGF 2a catalyzed generation of prostaglandin isomers. Thus it would and IPF 2a -I in patients with homozygous familial hypercholesappear that enzymatic formation of 8-epi PGF 2a by COX is a terolemia (HFH) and also in more moderate hypercholesteroltrivial contributor to overall 8-epi PGF 2a biosynthesis in vivo emia. Urinary excretion of these isoprostanes was increased in and should not detract from its usefulness as an index of oxiboth groups of hypercholesterolemic patients compared with dant stress. their respective controls. Furthermore, the concentration of 8-epi PGF 2a esterified in LDL was elevated and correlated with urinary excretion of this compound in a subset of these patients ISOPROSTANES AND OXIDANT STRESS (Reilly et al. 1996b) . Given the potentially distinct mechanisms that might result in free radical generation in smokers, Oxidative stress is thought to play an important pathophysiologic role in a variety of human diseases, including atheroscleone might anticipate an even greater increment in dyslipidemic individuals who smoke. Interestingly, the precise role rosis, cancer and neurodegenerative disorders. However, difficulty in assessing radical generation in vivo has proven to be of dietary lipids in isoprostane biosynthesis in normal individuals or in the setting of increased biosynthesis remains to be the major limitation to our understanding of this mechanism of human diseases. Traditional in vitro assays, directed against addressed definitively. Oxidant stress has been implicated in vascular reperfusion malondialdehyde or lipid hydroperoxides, are thought fallible when applied to clinical investigation, because of such factors after a period of ischemia. Examples include the regional myocardial stunning seen in animal models of coronary occlusion/ as ex vivo generation of products and both the instability and nonspecificity of the analytes involved. Furthermore, it is reperfusion and in some patients after thrombolytic therapy, as well as in the global myocardial dysfunction seen after coronary unclear how ex vivo estimates of free radical generation, such PGF 2a in a number of syndromes of myocardial reperfusion Fitzgerald, D. J. & FitzGerald, G. A. (1989) The role of thrombin and thrombox- 
The metabolic disposition of isoprostanes in vivo remains
(1994) J. Pharmacol. Exp. Ther. 271: 927-934, 1994. to be investigated. However, our experience with indices of lipids is expressed under pathophysiologic circumstances, in
